Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TWLXC
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
SBT-6290
|
|||||
| Synonyms |
SBT 6290; SBT-6290; SBT6290
Click to Show/Hide
|
|||||
| Organization |
Silverback Therapeutics, Inc.; ARS Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Phase 1/2 (Terminated)
|
|||||
| Indication |
In total 4 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Nectin-4 (NECTIN4)
|
Antigen Info | ||||
| Payload Name |
TLR8 agonist
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 8 (TLR8)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
